desert rock formation
pulmonologist jeremy feldman

Jeremy Feldman, MD

Pulmonologist
Accepting New Patients
Brain Surgery
+
More than 20 years experience treating people with HHT
+
Author of more than 50 peer-reviewed publications
Memberships
  Years
Voted to “Best Doctors” in Phoenix seven years running
Clinical Trials
+
Primary investigator for more than 30 clinical research studies

Jeremy Feldman, MD, FCCP, is a pulmonologist and director of the Hereditary Hemorrhagic Telangiectasia (HHT) Program (a collaboration with Arizona Pulmonary Specialists) at Barrow Neurological Institute. He is board certified in internal medicine, pulmonary disease, and critical care by the American Board of Medical Specialties. He is also board certified in neurocritical care by the Society of Neurological Surgeons Committee on Advanced Subspecialty Training.

Dr. Feldman is a nationally recognized expert in pulmonary vascular disease who has been caring for patients with HHT since the early 2000s. He is a member of the American Thoracic Society and a fellow of the American College of Chest Physicians.

Dr. Feldman earned his medical degree from the University of California San Diego School of Medicine and his bachelor’s degree in biology from Stanford University in California. He completed his internal medicine residency at Brigham and Women’s Hospital in Boston, a teaching affiliate of Harvard Medical School, and then underwent pulmonary and critical care training at the University of California San Francisco. He completed his training at Stanford University as the eBay fellow in pulmonary vascular disease.

Dr. Feldman has published extensively on pulmonary hypertension and has been involved in clinical trials for the condition throughout his career. His other research interests include idiopathic pulmonary fibrosis and interstitial lung disease.

Dr. Feldman has been a leader in developing web-based education content for patients with pulmonary hypertension and pulmonary fibrosis.

pulmonologist jeremy feldman

Jeremy Feldman, MD

Pulmonologist
Accepting New Patients
Brain Surgery
+
More than 20 years experience treating people with HHT
+
Author of more than 50 peer-reviewed publications
Memberships
  Years
Voted to “Best Doctors” in Phoenix seven years running
Clinical Trials
+
Primary investigator for more than 30 clinical research studies

Jeremy Feldman, MD, FCCP, is a pulmonologist and director of the Hereditary Hemorrhagic Telangiectasia (HHT) Program (a collaboration with Arizona Pulmonary Specialists) at Barrow Neurological Institute. He is board certified in internal medicine, pulmonary disease, and critical care by the American Board of Medical Specialties. He is also board certified in neurocritical care by the Society of Neurological Surgeons Committee on Advanced Subspecialty Training.

Dr. Feldman is a nationally recognized expert in pulmonary vascular disease who has been caring for patients with HHT since the early 2000s. He is a member of the American Thoracic Society and a fellow of the American College of Chest Physicians.

Dr. Feldman earned his medical degree from the University of California San Diego School of Medicine and his bachelor’s degree in biology from Stanford University in California. He completed his internal medicine residency at Brigham and Women’s Hospital in Boston, a teaching affiliate of Harvard Medical School, and then underwent pulmonary and critical care training at the University of California San Francisco. He completed his training at Stanford University as the eBay fellow in pulmonary vascular disease.

Dr. Feldman has published extensively on pulmonary hypertension and has been involved in clinical trials for the condition throughout his career. His other research interests include idiopathic pulmonary fibrosis and interstitial lung disease.

Dr. Feldman has been a leader in developing web-based education content for patients with pulmonary hypertension and pulmonary fibrosis.